Related Experiment Video
Updated: Jul 1, 2025
Real-Time Imaging of CCL5-Induced Migration of Periosteal Skeletal Stem Cells in Mice
Published on: September 16, 2020
Unraveling IGFBP3-mediated m6A modification in fracture healing
Aining Lai1, Junjian Sun2, Zhiyuan Dai3
1Section Ⅱ, Department of Orthopedics, the 72nd Army Hospital of PLA, Huzhou 313000, P. R. China.
Background:
This study investigates the role of IGFBP3-mediated m6A modification in regulating the miR-23a-3p/SMAD5 axis and its impact on fracture healing, aiming to provide insights into potential therapeutic targets.
Methods:
Utilizing fracture-related datasets, we identified m6A modification-related mRNA and predicted miR-23a-3p as a regulator of SMAD5. We established a mouse fracture healing model and conducted experiments, including Micro-CT, RT-qPCR, Alizarin Red staining, and Alkaline phosphatase (ALP) staining, to assess gene expression and osteogenic differentiation.
Results:
IGFBP3 emerged as a crucial player in fracture healing, stabilizing miR-23a-3p through m6A modification, leading to SMAD5 downregulation. This, in turn, inhibited osteogenic differentiation and delayed fracture healing. Inhibition of IGFBP3 partially reversed through SMAD5 inhibition, restoring osteogenic differentiation and fracture healing in vivo.
Conclusion:
The IGFBP3/miR-23a-3p/SMAD5 axis plays a pivotal role in fracture healing, highlighting the relevance of m6A modification. IGFBP3's role in stabilizing miR-23a-3p expression through m6A modification offers a potential therapeutic target for enhancing fracture healing outcomes.
Insights
Insulin-like growth factor-binding protein 3 (IGFBP3) stabilizes microRNA-23a-3p via m6A modification, impacting SMAD5 and delaying fracture healing. Targeting this pathway may improve bone repair.
Area of Science:
- Biochemistry
- Molecular Biology
- Regenerative Medicine
Background:
- Fracture healing is a complex process influenced by molecular signaling pathways.
- N6-methyladenosine (m6A) modification is increasingly recognized for its role in gene regulation.
- Understanding regulatory axes is crucial for developing novel therapeutic strategies.
Purpose of the Study:
- To investigate the role of IGFBP3-mediated m6A modification in regulating the miR-23a-3p/SMAD5 axis.
- To elucidate the impact of this axis on fracture healing.
- To identify potential therapeutic targets for enhancing bone repair.
Main Methods:
- Analysis of fracture-related datasets to identify m6A modification-related mRNA.
- Prediction of miR-23a-3p as a regulator of SMAD5.
- Establishment of a mouse fracture healing model.
- Assessment of gene expression and osteogenic differentiation using Micro-CT, RT-qPCR, Alizarin Red, and ALP staining.
Main Results:
- IGFBP3 was identified as a key regulator in fracture healing.
- IGFBP3 stabilizes miR-23a-3p through m6A modification, leading to SMAD5 downregulation.
- This pathway inhibited osteogenic differentiation and delayed fracture healing.
- Inhibition of IGFBP3 partially reversed these effects, restoring osteogenic differentiation and healing.
Conclusions:
- The IGFBP3/miR-23a-3p/SMAD5 axis is pivotal in fracture healing, underscoring the significance of m6A modification.
- IGFBP3's stabilization of miR-23a-3p via m6A modification presents a potential therapeutic target.
- Targeting this axis could offer novel strategies for improving fracture healing outcomes.
Related Concept Videos
01:16TGF - β Signaling Pathway
01:27Fractures: Bone Repair
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
01:17Intracellular Signaling Affects Focal Adhesions
Some...